Valneva SE (VALN) Prices 4.5M ADS Offering at $39.42/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Valneva Announces the Pricing of its Global Offering of American Depositary Shares and Ordinary Shares
October 29, 2021 1:00 AM EDTSaint-Herblain (France), October 29, 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the Company), a specialty vaccine company, announced today the pricing of 4,500,000 ordinary shares in a global offering to specified categories of investors comprised of a public offering of 16,560 American Depositary Shares (ADSs), each representing two ordinary shares, in the United States (the U.S. Offering), and a concurrent private placement of 4,466,880 ordinary shares in certain jurisdictions outside of the United States (the European Private... More
